LifeLens Technologies, Inc.
PrivateLast Round
Early Stage
VC
Nov 4, 2025
Total Funding Raised
$42.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LifeLens Technologies, Inc. operates in Healthcare & Life Sciences and is based in Ivyland, Pennsylvania. Its latest recorded funding round was an Early Funding round in November 2025.
LifeLens Technologies, Inc. is a healthtech company that develops wearable physiologic monitoring devices and AI-driven analytics for real-time remote patient monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Defense Tech, Health IoT, Sensors, Medical AI
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LifeLens Technologies, Inc. Comparables
Compare LifeLens Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sempulse | 86% | |
| Equivital | 83% | |
| Caretaker Medical | 83% |
For institutional investors. Book with your work email.
LifeLens Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Nov 4, 2025 | ||||
| Early Funding | Nov 4, 2025 | ||||
| Early Funding | Jul 15, 2024 | ||||
| Series A | Oct 15, 2021 | ||||
| Seed | Jul 20, 2020 | ||||
Debt | Jul 17, 2019 |
For institutional investors. Book with your work email.
LifeLens Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paragon Equity Partners | Series A, Early Funding |
| Valiance Asset Management | Early Funding |
| Brightstone Venture Capital | Early Funding |
| Highcroft Capital | Early Funding |
| Medical Technology Enterprise Consortium | Grant |
| Next Chapter Ventures | Seed, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM, reaching 2.8K.
- Jun 19, 2026
Monthly visitors increased 32% MoM to 3.2K.
For institutional investors. Book with your work email.
LifeLens Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LifeLens Technologies, Inc.'s valuation, stock price, and market status.
Is LifeLens Technologies, Inc. a public or private company?
LifeLens Technologies, Inc. is a private company.
What is the current stock price of LifeLens Technologies, Inc.?
LifeLens Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks LifeLens Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LifeLens Technologies, Inc. worth (valuation)?
Valuation information for LifeLens Technologies, Inc. is not publicly available.
Can I buy LifeLens Technologies, Inc. stock?
LifeLens Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LifeLens Technologies, Inc.'s last funding round?
LifeLens Technologies, Inc.'s most recent funding round was Early Stage VC on November 4, 2025.
Who are the main investors in LifeLens Technologies, Inc.?
Key investors in LifeLens Technologies, Inc. include Paragon Equity Partners, Valiance Asset Management, Brightstone Venture Capital, Highcroft Capital, Medical Technology Enterprise Consortium.
Will LifeLens Technologies, Inc. IPO soon?
No public IPO plans have been announced for LifeLens Technologies, Inc..
How can I track LifeLens Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in LifeLens Technologies, Inc.'s shares on secondary markets.